Cargando…
Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma
BACKGROUND: Downregulation of the putative tumor suppressor gene SLC22A18 has been reported in a number of human cancers. The aim of this study was to investigate the relationship between SLC22A18 downregulation, promoter methylation and the development and progression of human glioma. METHOD: SLC22...
Autores principales: | Chu, Sheng-Hua, Feng, Dong-Fu, Ma, Yan-Bin, Zhang, Hong, Zhu, Zhi-An, Li, Zhi-Qiang, Jiang, Pu-Cha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184631/ https://www.ncbi.nlm.nih.gov/pubmed/21936894 http://dx.doi.org/10.1186/1479-5876-9-156 |
Ejemplares similares
-
Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy
por: Chu, Sheng-Hua, et al.
Publicado: (2013) -
Upregulation of SATB1 is associated with the development and progression of glioma
por: Chu, Sheng-Hua, et al.
Publicado: (2012) -
Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression
por: Zhang, Yunwen, et al.
Publicado: (2023) -
DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma
por: Schaeffeler, Elke, et al.
Publicado: (2011) -
Hydroxyapatite nanoparticles inhibit the growth of human glioma cells in vitro and in vivo
por: Chu, Sheng-Hua, et al.
Publicado: (2012)